Trending News Today: Vizient Report Projects Increase in Health System Pharmacy Spending

A recent analysis projected a 4.28% increase in pharmaceutical spending by health systems between July 1, 2019 and June 30, 2020, The American Journal of Managed Care reported. According to the article, Vizient said that oncology medications, disease-modifying agents, and immunomodulatory agents will continue to account for most of the pharmacy spending. The report also noted that 2018 marked the highest number of new drug shortages since 2014, with 139 new drug shortages reported from January through September 2018, the article noted.   
 
Health insurer Aetna announced it is working with Apple to develop a new health app for Apple Watches, Reuters reported. According to the article, the new app, called Attain, will reward Aetna customers for meeting activity goals and fulfilling recommended tasks, such as getting vaccinations or refilling medications, with a subsidy toward the cost of an Apple Watch or gift cards for US retailers. The app will also use the individual’s personal heath data to provide customized goals and recommendations, the article reported.
 
A new initiative aims to educate women with inflammatory bowel disease (IBD) about how to manage their condition while conceiving, carrying a child, and giving birth, Reuters reported. According to the article, the IBD Parenthood Project from the American Gastroenterological Association provides a toolkit on the project’s website for women who are pregnant or considering pregnancy that includes fact sheets, a discussion guide, and a checklist of questions to go over with physicians. Overall, the project’s goal is to address common concerns, such as whether medications for IBD are harmful during pregnancy, the article reported.



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

Top news of the day from across the health care landscape.
Individuals with HIV maintained similar rates of viral suppression after switching from a 3-drug regimen to the 2-drug regimen of dolutegravir plus lamivudine.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$